X-Glc

CAS: 15548-60-4

Ref. IN-DA001NYJ

Produktinformation

• Name: X-Glc
• Synonyme: 5-Br-4-Cl-3-indoxyl-alpha-D-glucoside, 5-bromo-4-chloro-3-indolyl-beta-glucoside, 5-bromo-4-chloro-3-indoxylglucoside, 5-Bromo-4-chloro-3-indolyl-beta-D-glucoside, 5-Bromo-4-chloro-3-indolyl b-D-glucopyranoside, 5-Bromo-4-chloroindol-3-yl-beta-D-glucopyranoside, X-glucoside, 5-bromo-4-chloro-3-indolyl beta-d-glucoside, Indoxyl-Glucoside, (2S,3R,4S,5S,6R)-2-((5-Bromo-4-chloro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 5-Bromo-4-chloro-3-indoxylglucoside, 5-Bromo-4-chloro-3-indolyl |A-D-glucopyranoside, 5-Bromo-4-chloro-3-indoxyl-beta-D-glucopyranoside, beta-D-Glucopyranoside, 5-bromo-4-chloro-1H-indol-3-yl, 5-bromo-4-chloro-1h-indol-3-yl |A-d-glucopyranoside, 5-bromo-4-chloro-3-indolyl--d-glucoside, 5-bromo-4-chloro-3-indolyl -D-glucoside, 5-bromo-4-chloro-3-indolyl beta-glucoside, (-)-5-bromo-4-chloro-3-indolyl-beta-D-glucoside, 5-Bromo-4-chloro-3-indolyl beta-D-glucopyranoside, b-D-Glucopyranoside,5-bromo-4-chloro-1H-indol-3-yl, 5-bromo-4-chloro-1H-indol-3-yl beta-D-glucopyranoside, 5-Bromo-4-chloro-3-indolyl beta-D-glucopyranoside, >=97%, 5-bromo-4-chloro-3-indolyl--d-glucuronide cyclohexylammonium salt, (2S,3R,4S,5S,6R)-2-(5-bromo-4-chloro-1H-indol-3-yloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, (2S,3R,4S,5S,6R)-2-[(5-bromo-4-chloro-1H-indol-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol, (2S,3R,4S,5S,6R)-2-[(5-bromo-4-chloro-1H-indol-3-yl)oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol, X-Gluc, 5-Bromo-4-chloro-3-indolyl-b-D-glucopyranoside, 5-bromo-4-chloro-3-indolyl -beta-d-glucopyranoside, 5-Bromo-4-chloro-3-(beta-D-galactopyranosyloxy)indole, ss-D-Glucopyranoside, 5-bromo-4-chloro-1H-indol-3-yl
• Marke: Indagoo

Chemische Eigenschaften

• Molekulargewicht: 408.6290
• Formel: C₁₄H₁₅BrClNO₆
• Reinheit: 97%
• Farbe/Form: Solid
• InChl: InChI=1S/C14H15BrClNO6/c15-5-1-2-6-9(10(5)16)7(3-17-6)22-14-13(21)12(20)11(19)8(4-18)23-14/h1-3,8,11-14,17-21H,4H2/t8-,11-,12+,13-,14-/m1/s1
• InChI Key: OPIFSICVWOWJMJ-LNNRFACYSA-N